Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice.
Mol Metab
; 3(2): 177-90, 2014 Apr.
Article
em En
| MEDLINE
| ID: mdl-24634829
ABSTRACT
Pairing the selective estrogen receptor modulator bazedoxifene (BZA) with estrogen as a tissue-selective estrogen complex (TSEC) is a novel menopausal therapy. We investigated estrogen, BZA and TSEC effects in preventing diabetisity in ovariectomized mice during high-fat feeding. Estrogen, BZA or TSEC prevented fat accumulation in adipose tissue, liver and skeletal muscle, and improved insulin resistance and glucose intolerance without stimulating uterine growth. Estrogen, BZA and TSEC improved energy homeostasis by increasing lipid oxidation and energy expenditure, and promoted insulin action by enhancing insulin-stimulated glucose disposal and suppressing hepatic glucose production. While estrogen improved metabolic homeostasis, at least partially, by increasing hepatic production of FGF21, BZA increased hepatic expression of Sirtuin1, PPARα and AMPK activity. The metabolic benefits of BZA were lost in estrogen receptor-α deficient mice. Thus, BZA alone or in TSEC produces metabolic signals of fasting and caloric restriction and improves energy and glucose homeostasis in female mice.
AMPKα, AMP-activated protein kinase α; AUC, area-under the curve; Akt, protein kinase B; BAT, brown adipose tissue; BZA, bazedoxifene; Bazedoxifene; CE, conjugated equine estrogens; E2, 17ß-estradiol; ER, estrogen receptor; FAS, fatty acid synthase; FGF21, fibroblast growth factor 21; GIR, glucose infusion rate; H&E, hematoxylin and eosin; HFD, high-fat diet; HGP, hepatic glucose production; ITT, insulin tolerance test; Insulin resistance; LPL, lipoprotein lipase; Lcn2, lipocalin 2; Menopause; Metabolic syndrome; NAFLD, non-alcoholic fatty liver disease; OGTT, oral glucose tolerance test; OVX, ovariectomy; PTT, pyruvate tolerance test; RBP4, retinol binding protein 4; RER, respiratory exchange ratio; Rd, rate of whole-body glucose disappearance; SERM, selective estrogen receptor modulator; TBARS, thiobarbituric acid reactive substances; TG, triacylglycerol; TSEC, tissue-selective estrogen complex; Tissue-selective estrogen complexes; Type 2 diabetes; UCPs, uncoupling proteins; VO2, oxygen consumption; WAT, white adipose tissue.
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article